Browse Category

Analyst Insights News 14 December 2025 - 16 December 2025

ICICI Bank Share Price Today (16 December 2025): Key News, Analyst Targets, and What’s Driving ICICIBANK Stock

ICICI Bank Share Price Today (16 December 2025): Key News, Analyst Targets, and What’s Driving ICICIBANK Stock

Mumbai | December 16, 2025 — ICICI Bank Limited (NSE: ICICIBANK, BSE: 532174) is trading in a cautious zone on Tuesday as investors weigh a softer broader market, a fresh regulatory overhang linked to insurance distribution commissions, and the final day of bidding for the ICICI Prudential AMC IPO—an event closely watched by shareholders because of ICICI Bank’s stake and strategic linkage. As of 12:23 PM IST, ICICI Bank was around ₹1,363 with a marginal decline on the day, while market participants tracked headline risks such as sustained foreign selling and a weakening rupee, both of which have been pressuring
Core Scientific (CORZ) Stock Drops on Dec. 15, 2025: Latest News, Analyst Price Targets, and What Investors Are Watching

Core Scientific (CORZ) Stock Drops on Dec. 15, 2025: Latest News, Analyst Price Targets, and What Investors Are Watching

Core Scientific, Inc. (NASDAQ: CORZ) stock traded sharply lower on Monday, December 15, 2025, as investors recalibrated risk across crypto- and AI-infrastructure-linked names. By mid-afternoon, CORZ was hovering around $15.2–$15.3, down roughly 7%–8% on the session after opening near $16.50. The day’s range stretched from about $15.25 on the low end to roughly $16.69 at the high, highlighting the kind of intraday volatility traders have come to expect from the stock. StockAnalysis+1 That volatility is happening in a bigger narrative shift: Core Scientific is no longer “just” a bitcoin miner in the public imagination. It’s increasingly valued as a digital
Catalyst Pharmaceuticals CPRX Stock News, Forecasts and Analyst Outlook for December 15, 2025

Catalyst Pharmaceuticals CPRX Stock News, Forecasts and Analyst Outlook for December 15, 2025

December 15, 2025 — Catalyst Pharmaceuticals, Inc. (Nasdaq: CPRX) is getting fresh attention on Monday as the company tees up a high-visibility appearance at the J.P. Morgan Healthcare Conference early next year, while traders and analysts continue to debate the stock’s “next leg” after a strong 2025 run in rare-disease commercialization. At the same time, the backdrop around Catalyst is unusually rich with “moving parts” that matter to stockholders: a large cash position, an active share repurchase authorization, a product portfolio that’s growing (FIRDAPSE and AGAMREE) while also facing predictable generic pressure (FYCOMPA), and Wall Street price targets that still
Lumentum (LITE) Stock Rebounds on Dec. 15 After AI Sell-Off: Today’s News, Analyst Targets, and What’s Next

Lumentum (LITE) Stock Rebounds on Dec. 15 After AI Sell-Off: Today’s News, Analyst Targets, and What’s Next

Dec. 15, 2025 — Lumentum Holdings Inc. (NASDAQ: LITE) is back in the spotlight after a sharp reversal to start the week. The optical and photonics supplier—widely viewed as a key “picks-and-shovels” name for AI data center networking—is bouncing after last week’s sudden drop, a move that highlighted just how sensitive the AI infrastructure trade has become to shifts in sentiment. As of late morning trading Monday (Dec. 15), LITE was changing hands around $336, up about 3.7% on the day, after swinging between roughly $325 and $348. That follows a steep Friday slide and sets up a familiar 2025
Microsoft Stock (MSFT) Today: Fresh Analyst Targets, UK Cloud Lawsuit Risk, and AI Catalysts Investors Are Watching on Dec. 15, 2025

Microsoft Stock (MSFT) Today: Fresh Analyst Targets, UK Cloud Lawsuit Risk, and AI Catalysts Investors Are Watching on Dec. 15, 2025

Microsoft Corp. (NASDAQ: MSFT) began the week under a familiar spotlight: Wall Street still sees Microsoft as one of the most important “AI infrastructure + enterprise software” plays in global markets, but investors are also weighing the costs and constraints of the AI buildout—plus rising legal and regulatory scrutiny tied to cloud licensing. As of the latest available trading update on Monday, Dec. 15, 2025, MSFT traded around $477.90, down about 0.13% on the day, after opening near $480.11 and moving between roughly $477.05 and $480.26 intraday. Microsoft’s market capitalization stood near $3.85 trillion, with a P/E ratio around 36.7
Rheinmetall Aktie Today (15 December 2025): Share Price Slides on Berlin Peace Talks, Despite Tank Megaproject Approval and Bullish Analyst Targets

Rheinmetall Aktie Today (15 December 2025): Share Price Slides on Berlin Peace Talks, Despite Tank Megaproject Approval and Bullish Analyst Targets

Rheinmetall Aktie (Rheinmetall AG shares) traded lower on Monday, 15 December 2025, as markets digested fresh developments around high-level Ukraine talks in Berlin—headlines that have recently been enough to move Europe’s defence stocks even when company fundamentals remain strong. By late morning/early afternoon trading, Rheinmetall shares were down roughly 2–3%, with Reuters reporting a 2.8% drop as defence names broadly slipped. Reuters The pullback came despite a notable piece of supportive news for Rheinmetall’s longer-term land-systems pipeline: Germany’s competition authority, the Bundeskartellamt, has approved an expansion of a Rheinmetall-KNDS joint venture framework to support a future Bundeswehr main battle tank project—an “interim solution” designed to bridge capability needs
Macquarie Group (ASX:MQG) Stock Update — 15 Dec 2025: Share Price Moves, Dividend Countdown, Buyback, and Analyst Forecasts

Macquarie Group (ASX:MQG) Stock Update — 15 Dec 2025: Share Price Moves, Dividend Countdown, Buyback, and Analyst Forecasts

Sydney, 15 December 2025 — Macquarie Group Limited (ASX:MQG; ADR: MQBKY) entered the final full trading weeks of the year with investors juggling three big storylines at once: a near-term dividend payment, a capital-management program that can keep soaking up stock, and a debate about whether the group’s earnings engine is merely “between cycles” or structurally cooling. Macquarie On the tape, the day was mildly negative. Macquarie shares finished around A$200.2 on 15 December, down roughly 0.7%, after trading between ~A$199.38 and ~A$202.93. Investing.com Beneath that modest move is a more interesting question: what is the market paying for Macquarie
Trane Technologies (TT) Stock: Key News, Analyst Targets, and Earnings Outlook Before the U.S. Market Opens on Dec. 15, 2025

Trane Technologies (TT) Stock: Key News, Analyst Targets, and Earnings Outlook Before the U.S. Market Opens on Dec. 15, 2025

Trane Technologies plc (NYSE: TT) heads into the Monday, December 15, 2025 U.S. market open after a weak finish to last week. Shares closed Friday, Dec. 12 at $391.19, down 3.02%, snapping a three-day winning streak and leaving the stock about 17.85% below its $476.19 52‑week high set on July 28. Trading volume rose to about 1.6 million shares, above the stock’s 50‑day average, as industrial and building-products names broadly tracked a down day for the major indexes. MarketWatch For investors watching TT stock before the opening bell, the story remains a familiar one: Trane is leaning harder into high-growth,
Nvidia Stock (NVDA) Before the Market Opens Dec. 15, 2025: Latest News, Key Catalysts, Analyst Targets, and Risks

Nvidia Stock (NVDA) Before the Market Opens Dec. 15, 2025: Latest News, Key Catalysts, Analyst Targets, and Risks

Nvidia stock heads into the Monday, Dec. 15, 2025 U.S. market open with investors balancing two powerful—and competing—forces: the company’s still-dominant position in AI infrastructure, and a fresh wave of market anxiety about whether the AI boom is getting ahead of fundamentals. Shares slid with the broader tech complex on Friday as “AI payoff” jitters resurfaced across semiconductors, fueled by high-profile earnings reactions elsewhere in the AI ecosystem. Nvidia fell about 3.3% in that session, one of the heaviest weights on the S&P 500 on the day. Reuters Below is what to know heading into Monday’s open—covering the biggest headlines, what analysts are forecasting, and
Fermi Inc. (FRMI) Stock News Today: $150M Funding Deal Terminated, Project Matador Updates, and Analyst Price Targets (Dec. 14, 2025)

Fermi Inc. (FRMI) Stock News Today: $150M Funding Deal Terminated, Project Matador Updates, and Analyst Price Targets (Dec. 14, 2025)

December 14, 2025 — Fermi Inc. (NASDAQ: FRMI, LSE: FRMI) is in the spotlight after a dramatic selloff tied to a sudden change in its earliest tenant and financing narrative for Project Matador, the company’s flagship “behind-the-meter” power-and-data campus planned for West Texas. The drop has intensified debate over whether FRMI is a long-term AI-infrastructure winner trading at a steep discount—or a pre-revenue execution story facing its first major stress test. As of the most recent quote available heading into Sunday (markets closed), FRMI traded around $10.09 after a volatile week that included a heavy-volume plunge and a wide intraday
Plug Power (PLUG) Stock News Today: Latest Headlines, Analyst Forecasts, and Key Catalysts to Watch (Dec. 14, 2025)

Plug Power (PLUG) Stock News Today: Latest Headlines, Analyst Forecasts, and Key Catalysts to Watch (Dec. 14, 2025)

As of Sunday, December 14, 2025, U.S. markets are closed. Plug Power Inc. (NASDAQ: PLUG) last traded on Friday, Dec. 12, when the stock finished at $2.32, down 1.69% on the session, after a strong multi-day bounce earlier in the week. MarketWatch For investors tracking hydrogen and fuel-cell names, Plug Power remains a high-volatility, headline-driven stock: the company has recently paired new commercial progress (NASA liquid hydrogen supply, EU electrolyzer activity) with major balance-sheet and governance events (convertible notes financing, and a January 2026 shareholder vote tied to share authorization). SEC+3Plug Power+3Plug Power+3 Key takeaways for PLUG stock on Dec.
UnitedHealth Group (UNH) Stock News and Forecasts on Dec. 14, 2025: DOJ-Amedisys Deal, Optum Opioid Lawsuit, Earnings Date, and Analyst Targets

UnitedHealth Group (UNH) Stock News and Forecasts on Dec. 14, 2025: DOJ-Amedisys Deal, Optum Opioid Lawsuit, Earnings Date, and Analyst Targets

Updated: December 14, 2025 UnitedHealth Group Incorporated (NYSE: UNH) is ending the weekend with a rare combination for a Dow heavyweight: a near-term relief catalyst (a key court-approved DOJ settlement tied to the Amedisys deal) alongside fresh legal headline risk (West Virginia’s opioid-related lawsuit targeting Optum). Add an upcoming full-year 2025 earnings release with 2026 guidance in late January, and UNH stock enters the final stretch of 2025 as one of the market’s most closely watched healthcare bellwethers. Department of Justice+2Reuters+2 Below is the full roundup of the most current news, forecasts, and analyst commentary available as of 14.12.2025, plus
1 19 20 21 22 23 29

Stock Market Today

Keppel stock holds near 12-year high after profit jump, special dividend; buyback adds support

Keppel stock holds near 12-year high after profit jump, special dividend; buyback adds support

7 February 2026
Singapore, February 7, 2026, 15:11 SGT — Market closed. Shares of Singapore’s Keppel Ltd (SGX:BN4) ended Friday at S$11.64, up 0.17%, with the market shut for the weekend and traders eyeing whether the post-results bid carries into Monday. A filing showed Keppel bought back 151,400 shares on Feb. 6 at prices between S$11.38 and S$11.55, spending about S$1.74 million including costs. (ShareInvestor) The stock had surged 6.1% on Thursday to close at S$11.62 after Keppel reported higher FY2025 earnings and laid out a larger distribution, sending the counter to its highest level in more than 12 years. That move did
ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

7 February 2026
ST Engineering shares fell 1.9% to S$9.71 Friday, outpacing the Singapore market’s 0.8% drop amid a tech-led selloff. The company signed a deal with Shield AI at the Singapore Airshow to integrate autonomy software into its unmanned platforms and unveiled a small drone capable of carrying explosives. About 6.9 million shares traded as investors await full-year results on Feb. 27.
Go toTop